Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Journal of Alzheimer's Disease · 16.04.2024 · 98 (4) · 1243-1275
DOI: 10.3233/jad-231318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 16.04.2024. Verfasst von Estela Area-Gomez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 427 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
The “amyloid cascade” hypothesis of Alzheimer’s disease (AD) pathogenesis invokes the accumulation in the brain of plaques (containing the amyloid-β protein precursor [AβPP] cleavage product amyloid-β [Aβ]) and tangles (containing hyperphosphorylated tau) as drivers of pathogenesis. However, the poor track record of clinical trials based on this hypothesis suggests that the accumulation of these peptides is not the only cause of AD. Here, an alternative hypothesis is proposed in which the AβPP cleavage product C99, not Aβ, is the main culprit, via its role as a regulator of cholesterol metabolism. C99, which is a cholesterol sensor, promotes the formation of mitochondria-associated endoplasmic reticulum (ER) membranes (MAM), a cholesterol-rich lipid raft-like subdomain of the ER that communicates, both physically and biochemically, with mitochondria. We propose that in early-onset AD (EOAD), MAM-localized C99 is elevated above normal levels, resulting in increased transport of cholesterol from the plasma membrane to membranes of intracellular organelles, such as ER/endosomes, thereby upregulating MAM function and driving pathology. By the same token, late-onset AD (LOAD) is triggered by any genetic variant that increases the accumulation of intracellular cholesterol that, in turn, boosts the levels of C99 and again upregulates MAM function. Thus, the functional cause of AD is upregulated MAM function that, in turn, causes the hallmark disease phenotypes, including the plaques and tangles. Accordingly, the MAM hypothesis invokes two key interrelated elements, C99 and cholesterol, that converge at the MAM to drive AD pathogenesis. From this perspective, AD is, at bottom, a lipid disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Columbia University, New York, NY, USA.
- Centro de Investigaciones Biológicas "Margarita Salas", Spanish National Research Council, Madrid, Spain.
- Department of Genetics and Development>, Columbia University, New York, NY, USA.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
Zitieren
APA
Area-Gomez, E., & Schon, E. A. (2024). Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer's Disease, 98(4), 1243-1275. https://doi.org/10.3233/jad-231318
Vancouver
Area-Gomez E, Schon EA. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer's Disease. 2024;98(4):1243-1275. doi:10.3233/jad-231318
BibTeX
@article{AreaGomez2024,
author = {Area-Gomez, Estela and Schon, Eric A},
title = {Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis},
journal = {Journal of Alzheimer's Disease},
year = {2024},
volume = {98},
number = {4},
pages = {1243--1275},
doi = {10.3233/jad-231318}
}
EUVIMED